RxDoctor Payments Data

Ahmed Abdel-Latif, MD

Interventional Cardiology · Ann Arbor, MINPI 1518181239

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Amgen at 37.9% of the total. That places this record below the midpoint for interventional cardiology clinicians in MI, where the typical reported total is $6,857.

$71in general payments, 2019–2025

Across 4 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$27
  • Abiomed$21
  • Abbott$12
  • Elutia, Inc.$10
$165,758in research payments, 2019–2025

Across 9 payments — averaging $18,418 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lexicon Pharmaceuticals, Inc.$163K
  • Abbott$3K

What the payments were for

  • Food & beverage$71100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen1$27
Abiomed1$21
Abbott1$12
Elutia, Inc.1$10

How this compares

$71 in reported general payments places this provider in the 0th percentile of 187 interventional cardiology providers in Michigan.

See all interventional cardiology providers in Michigan

Medicare billing

Part B allowed, 2024
$19,232
Medicare patients
44
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →